Ocular Hypotensive Efficacy and Safety of the Rho Kinase Inhibitor AR-12286 in Patients With Elevated Intraocular Pressure

被引：0
|
作者：
Williams, R. D. [1 ]
Novack, G. D. [2 ]
van Haarlem, T. [3 ]
Kopczynski, C. [4 ]
机构：
[1] Clin Res Ctr, Louisville, KY USA
[2] PharmaLog Dev Inc, San Rafael, CA USA
[3] Aerie Pharmaceut Inc, Bridgewater, NJ USA
[4] Aerie Pharmaceut Inc, Res Triangle Pk, NC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
intraocular pressure; trabecular meshwork; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1633
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
    Sentaro Kusuhara
    Atsuko Katsuyama
    Wataru Matsumiya
    Makoto Nakamura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 809 - 814
  • [32] Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
    Kusuhara, Sentaro
    Katsuyama, Atsuko
    Matsumiya, Wataru
    Nakamura, Makoto
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (04) : 809 - 814
  • [33] Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
    Sturdivant, Jill
    Williams, Stuart S. S.
    Ina, Maria
    Weksler, Meredith
    McDougal, Alan
    Clancy, Daphne
    deLong, Mitchell A. A.
    Girouard, Natalie
    Zaretskaia, Maria
    Brennan, Karen
    Glendenning, Angela
    Foley, Briana
    Lin, Cheng-Wen
    White, Jeffrey C. C.
    Kopczynski, Casey
    Kelly, Curtis R. R.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (02) : 117 - 127
  • [34] LEVOBUNOLOL AND BETAXOLOL - A DOUBLE-MASKED CONTROLLED COMPARISON OF EFFICACY AND SAFETY IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE
    LONG, DA
    JOHNS, GE
    MULLEN, RS
    BOWE, RG
    ALEXANDER, D
    EPSTEIN, DL
    WEISS, MJ
    MASI, RJ
    CHARAP, AD
    ETO, CY
    NOVACK, GD
    OPHTHALMOLOGY, 1988, 95 (06) : 735 - 741
  • [35] Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure
    Rusk, C
    Sharpe, E
    Laurence, J
    Polis, A
    Adamsons, I
    CLINICAL THERAPEUTICS, 1998, 20 (03) : 454 - 466
  • [36] Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension
    Ge Jian
    Sun Xing-huai
    Wang Ning-li
    Zhao Jia-liang
    Wu Ling-ling
    Chen Xiao-ming
    Wang Zhi-xin
    Li, Benny
    CHINESE MEDICAL JOURNAL, 2010, 123 (11) : 1417 - 1421
  • [37] Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
    Pozarowska, Dorota
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 1229 - 1236
  • [38] Effects of Rho-associated. protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility
    Honjo, M
    Tanihara, H
    Inatani, M
    Kido, N
    Sawamura, T
    Yue, BYJT
    Narumiya, S
    Honda, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (01) : 137 - 144
  • [39] Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
    Li, Guorong
    Lee, Chanyoung
    Read, A. Thomas
    Wang, Ke
    Ha, Jungmin
    Kuhn, Megan
    Navarro, Iris
    Cui, Jenny
    Young, Katherine
    Gorijavolu, Rahul
    Sulchek, Todd
    Kopczynski, Casey
    Farsiu, Sina
    Samples, John
    Challa, Pratap
    Ethier, C. Ross
    Stamer, W. Daniel
    ELIFE, 2021, 10
  • [40] Rilmenidine: Safety and efficacy on intraocular pressure in healthy volunteers and glaucoma patients
    Nordmann, JP
    Elena, PP
    Mandrino, P
    Castagne, I
    Vilain, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2600 - 2600
12345